These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1477928)

  • 1. Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits.
    Watanabe Y; Matsumoto Y; Kawamoto K; Yazawa S; Matsumoto M
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3100-4. PubMed ID: 1477928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits.
    Watanabe Y; Matsumoto Y; Seki M; Takase M; Matsumoto M
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3042-7. PubMed ID: 1477920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
    Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
    J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-beta-cyclodextrin following nasal administration.
    Ahsan F; Arnold JJ; Meezan E; Pillion DJ
    Pharm Res; 2001 May; 18(5):608-14. PubMed ID: 11465415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins.
    Zhang Y; Jiang XG; Yao J
    Acta Pharmacol Sin; 2001 Nov; 22(11):1051-6. PubMed ID: 11749800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.
    Shao Z; Krishnamoorthy R; Mitra AK
    Pharm Res; 1992 Sep; 9(9):1157-63. PubMed ID: 1409397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of modified beta-cyclodextrins on pharmacological activity and bioavailability of 4-biphenylacetic acid in rats after oral administration.
    Puglisi G; Ventura CA; Spadaro A; Campana G; Spampinato S
    J Pharm Pharmacol; 1995 Feb; 47(2):120-3. PubMed ID: 7602465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal insulin delivery with dimethyl-beta-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations.
    Schipper NG; Romeijn SG; Verhoef JC; Merkus FW
    Pharm Res; 1993 May; 10(5):682-6. PubMed ID: 8321831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylated beta-cyclodextrins are able to improve the nasal absorption of salmon calcitonin.
    Schipper NG; Verhoef JC; Romeijn SG; Merkus FW
    Calcif Tissue Int; 1995 Apr; 56(4):280-2. PubMed ID: 7767838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of subcutaneous bioavailability of insulin by sulphobutyl ether beta-cyclodextrin in rats.
    Tokihiro K; Arima H; Tajiri S; Irie T; Hirayama F; Uekama K
    J Pharm Pharmacol; 2000 Aug; 52(8):911-7. PubMed ID: 11007061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release characteristics of endogenous constituents by exposure of small intestine to modified beta-cyclodextrins.
    Tanino T; Ogiso T; Iwaki M; Yamaguchi T; Kakehi K
    Biol Pharm Bull; 1999 Oct; 22(10):1099-105. PubMed ID: 10549863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
    Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
    Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin.
    Abe K; Irie T; Uekama K
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2232-7. PubMed ID: 8582025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyclodextrins on biological membrane. II. Mechanism of enhancement on the intestinal absorption of non-absorbable drug by cyclodextrins.
    Nakanishi K; Nadai T; Masada M; Miyajima K
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1252-6. PubMed ID: 1394642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
    Sinswat P; Tengamnuay P
    Int J Pharm; 2003 May; 257(1-2):15-22. PubMed ID: 12711157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of nasal bioavailability of luteinizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats.
    Matsubara K; Abe K; Irie T; Uekama K
    J Pharm Sci; 1995 Nov; 84(11):1295-300. PubMed ID: 8587046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository.
    Arima H; Kondo T; Irie T; Uekama K
    J Pharm Sci; 1992 Nov; 81(11):1119-25. PubMed ID: 1447717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.
    Hirayama F; Mieda S; Miyamoto Y; Arima H; Uekama K
    J Pharm Sci; 1999 Oct; 88(10):970-5. PubMed ID: 10514341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats.
    Merkus FW; Verhoef JC; Romeijn SG; Schipper NG
    Pharm Res; 1991 May; 8(5):588-92. PubMed ID: 1866372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
    Arima H; Yunomae K; Hirayama F; Uekama K
    J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.